Market closedNon-fractional

iRadimed/IRMD

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About iRadimed

iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.

Ticker

IRMD

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

Winter Springs, United States

Employees

148

iRadimed Metrics

BasicAdvanced
$557M
Market cap
31.42
P/E ratio
$1.40
EPS
0.87
Beta
$0.15
Dividend rate
0.34%
Dividend yield
$557M
0.87
$0.15
9.438
5.925
1.996
2.546
44.50%
15.87%
25.52%
31.421
8.2
7.13
7.13
51.521
0.34%
19.87%
28.40%
28.01%
158.87%

What the Analysts think about iRadimed

Analyst Ratings

Majority rating from 2 analysts.
Buy

iRadimed Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
23.42% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$18M
0.57%
Net income
$4.1M
-8.89%
Profit margin
23.42%
-9.44%

iRadimed Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 7.46%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.36
$0.43
$0.39
$0.36
-
Expected
$0.31
$0.36
$0.40
$0.34
$0.37
Surprise
16.13%
18.35%
-1.68%
7.46%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for iRadimed stock?

iRadimed (IRMD) has a market cap of $557M as of July 05, 2024.

What is the P/E ratio for iRadimed stock?

The price to earnings (P/E) ratio for iRadimed (IRMD) stock is 31.42 as of July 05, 2024.

Does iRadimed stock pay dividends?

Yes, the iRadimed (IRMD) stock pays dividends to shareholders. As of July 05, 2024, the dividend rate is $0.15 and the yield is 0.34%. iRadimed has a payout ratio of 44.5% on a trailing twelve-month basis.

When is the next iRadimed dividend payment date?

The next iRadimed (IRMD) dividend payment date is unconfirmed.

What is the beta indicator for iRadimed?

iRadimed (IRMD) has a beta rating of 0.87. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell iRadimed stock

Buy or sell iRadimed stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing